ÂÜÀòÂÒÂ×

Allene M. Diaz has served as a member of the Board of Directors since March 2021. Since August 2020, she has led AMD Consulting, a new product strategy and portfolio management consulting practice. Ms. Diaz held the position of Senior Vice President of R&D Portfolio Management at GlaxoSmithKline from September 2019 to June 2020. From May 2015 to September 2019, she served as the Senior Vice President of Global Commercial Development and Program Strategy and as a member of the Executive Leadership Team at TESARO. She was integrally involved in the acquisition of TESARO by GlaxoSmithKline in January 2019.

Prior to joining TESARO in 2015, Ms. Diaz held a variety of leadership roles in the EMD Serono and Merck Serono divisions of Merck KGaA, including Senior Vice President, Managed Markets, Senior Vice President, Head of U.S. Oncology Commercial, Vice President, Oncology Marketing, Head of Oncology Global Strategic Planning and Head of the Global Oncology Business Unit. Earlier in her career, Ms. Diaz held management, operating, sales and medical affairs roles at various biopharmaceutical companies, including Pfizer, Biogen and Amylin Pharmaceuticals among others.

Ms. Diaz has been a member of the Board of Directors of Allena Pharmaceuticals since April 2019 and a member of the Board of Directors of BCLS Acquisition Corp. since August 2020. Ms. Diaz previously served on the board of directors of Erytech Pharma SA, a biopharmaceutical company developing innovative therapies for cancer, from September 2016 to September 2019. Ms. Diaz earned a B.S. in Psychology from Florida State University.